Drugs / BAY1902607
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03789890 | Jan → Mar 2019 | — | Bayer | Completed | No outcome recorded |
| Phase 1 | NCT03212586 | Jul 2017 → May 2018 | — | Bayer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY1902607 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03212586 ↗ |
| Route | Oral | “Increasing Single Oral Doses of BAY1902607” NCT03212586 ↗ |